Peptide Finder US
PeptideFinder

Tesamorelin Clinics in Maryland

7 physician-supervised clinics prescribing Tesamorelin for Maryland residents — 5 in-state locations plus 2 telehealth providers. Compare consultation fees, treatment areas, and access before you enquire.

In-state clinics (5)

Nava Health logo
Nava Health
Columbia, Maryland
Physician-supervised

Consult

Both

Consult Fee

Not published

Injury RecoveryWeight ManagementMuscle & Performance
Physician-led
Call Clinic

Website only

C
Chesapeake Express IV
Annapolis, Maryland

Consult

Both

Consult Fee

Not published

Injury RecoveryWeight ManagementLongevity & NAD+
Call Clinic

Online booking

H
HITx Regenerative Health
Rockville, Maryland
Physician-supervised

Consult

Both

Consult Fee

USD $99

Injury RecoveryWeight ManagementMuscle & Performance
Physician-led
Send Inquiry

Free inquiry - no obligation

New Life Wellness logo
New Life Wellness
Gaithersburg, Maryland
Physician-supervised

Consult

Both

Consult Fee

Free consultation

Injury RecoveryWeight ManagementMuscle & Performance
Physician-ledFree Inquiry Form
Send Inquiry

Free inquiry - no obligation

WellnessMD logo
WellnessMD
Odenton, Maryland
Physician-supervised

Consult

Both

Consult Fee

Not published

Injury RecoveryWeight ManagementMuscle & Performance
Physician-led
Send Inquiry

Free inquiry - no obligation

Telehealth providers serving Maryland (2)

I
Irvine Health
Irvine, California
Physician-supervised

Consult

Telehealth

Consult Fee

Not published

Injury RecoveryWeight ManagementLongevity & NAD+
Physician-led
Send Inquiry

Free inquiry - no obligation

Hormones +Wellness by SDBotox logo
Hormones +Wellness by SDBotox
San Diego, California
Physician-supervised

Consult

Both

Consult Fee

Not published

Injury RecoveryWeight ManagementMuscle & Performance
Physician-led
Send Inquiry

Free inquiry - no obligation

Tesamorelin clinics in other states

About Tesamorelin

Tesamorelin is an FDA-approved synthetic GHRH analogue - the only active GH-releasing peptide with full US marketing authorization. It was approved as Egrifta in 2010 for the reduction of excess abdominal fat (lipodystrophy) in HIV-positive patients on antiretroviral therapy.

Read the full Tesamorelin guide →